HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gautam Sethi Selected Research

fangchinoline (limacine)

1/2022Fangchinoline diminishes STAT3 activation by stimulating oxidative stress and targeting SHP-1 protein in multiple myeloma model.
10/2018Molecular Targets Modulated by Fangchinoline in Tumor Cells and Preclinical Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gautam Sethi Research Topics

Disease

263Neoplasms (Cancer)
11/2022 - 11/2005
66Neoplasm Metastasis (Metastasis)
01/2022 - 07/2006
46Carcinogenesis
06/2022 - 06/2006
36Inflammation (Inflammations)
06/2022 - 02/2006
30Breast Neoplasms (Breast Cancer)
02/2022 - 04/2007
28Hepatocellular Carcinoma (Hepatoma)
10/2021 - 06/2010
27Multiple Myeloma
01/2022 - 03/2007
14Prostatic Neoplasms (Prostate Cancer)
02/2022 - 04/2007
12Lung Neoplasms (Lung Cancer)
05/2022 - 04/2007
11Chronic Disease (Chronic Diseases)
01/2022 - 06/2007
10Carcinoma (Carcinomatosis)
04/2019 - 04/2007
9Stomach Neoplasms (Stomach Cancer)
06/2019 - 09/2011
7Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 09/2006
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 02/2007
7Squamous Cell Carcinoma of Head and Neck
01/2022 - 08/2013
6Body Weight (Weight, Body)
01/2022 - 01/2012
6Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2005
6Leukemia
01/2021 - 03/2006
5Hematologic Neoplasms (Hematological Malignancy)
02/2022 - 05/2015
5Mouth Neoplasms (Oral Cancer)
01/2022 - 06/2007
5Arthritis (Polyarthritis)
08/2019 - 11/2005
5Asthma (Bronchial Asthma)
08/2019 - 04/2011
5Colonic Neoplasms (Colon Cancer)
01/2019 - 01/2016
4Adenocarcinoma
06/2022 - 10/2011
4Melanoma (Melanoma, Malignant)
02/2022 - 06/2007
4Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2014
4Necrosis
01/2021 - 06/2007
4Hypoxia (Hypoxemia)
01/2021 - 02/2012
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2019 - 01/2009
4Colorectal Neoplasms (Colorectal Cancer)
03/2019 - 01/2016
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2022 - 02/2015
3Hypertension (High Blood Pressure)
01/2022 - 01/2018
3Triple Negative Breast Neoplasms
09/2021 - 03/2016

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2007
41NF-kappa B (NF-kB)IBA
01/2022 - 02/2006
41Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2006
31STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2022 - 05/2007
22Pharmaceutical PreparationsIBA
11/2022 - 09/2006
18CytokinesIBA
06/2022 - 02/2006
16Biological ProductsIBA
06/2022 - 07/2012
15Phosphotransferases (Kinase)IBA
01/2021 - 09/2006
14Biomarkers (Surrogate Marker)IBA
05/2022 - 04/2014
13MicroRNAs (MicroRNA)IBA
06/2022 - 01/2014
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2018 - 03/2006
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019 - 02/2006
11EnzymesIBA
01/2021 - 06/2007
11AntioxidantsIBA
09/2020 - 01/2011
11TriterpenesIBA
06/2019 - 03/2006
10PhytochemicalsIBA
01/2022 - 11/2012
10Matrix Metalloproteinases (MMPs)IBA
01/2021 - 02/2006
10Cyclin D1IBA
03/2015 - 02/2006
9Antineoplastic Agents (Antineoplastics)IBA
11/2022 - 01/2012
9Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 02/2012
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2011
9Bortezomib (Velcade)FDA Link
12/2019 - 05/2007
9SurvivinIBA
10/2015 - 02/2006
8CurcuminIBA
01/2022 - 11/2005
8celastrolIBA
09/2021 - 04/2007
8Therapeutic UsesIBA
01/2021 - 11/2012
8Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2019 - 02/2006
8thymoquinoneIBA
01/2018 - 07/2008
7CateninsIBA
06/2022 - 01/2017
7Cisplatin (Platino)FDA LinkGeneric
01/2022 - 10/2012
7Mitogen-Activated Protein KinasesIBA
01/2021 - 02/2007
7LigandsIBA
11/2017 - 11/2010
7Ursolic AcidIBA
10/2016 - 09/2007
6CarcinogensIBA
01/2020 - 11/2006
6Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2019 - 02/2012
6TocotrienolsIBA
02/2019 - 05/2011
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 06/2007
6ResveratrolIBA
12/2017 - 03/2007
5Circular RNAIBA
06/2022 - 01/2020
5Neuroprotective AgentsIBA
01/2022 - 02/2017
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2012
5Cadherins (E-Cadherin)IBA
11/2020 - 12/2016
5Protein Kinases (Protein Kinase)IBA
11/2019 - 05/2007
5Paclitaxel (Taxol)FDA LinkGeneric
06/2019 - 02/2007
5buteinIBA
02/2017 - 06/2007
5Emodin (Archin)IBA
01/2017 - 01/2013
4Oncogene Proteins (Oncogene Protein)IBA
08/2022 - 01/2018
4Insulin (Novolin)FDA Link
01/2022 - 11/2014
4Histone Deacetylase InhibitorsIBA
09/2021 - 10/2016
4DiosgeninIBA
09/2021 - 06/2010
4bergamottinIBA
03/2021 - 11/2014
4Caspase 3 (Caspase-3)IBA
01/2021 - 01/2012
4Simvastatin (Zocor)FDA LinkGeneric
01/2021 - 02/2007
4TOR Serine-Threonine KinasesIBA
01/2021 - 05/2014
4UbiquitinIBA
03/2020 - 01/2018
4Ligases (Synthetase)IBA
03/2020 - 01/2018
4JNK Mitogen-Activated Protein KinasesIBA
11/2019 - 06/2007
4garcinolIBA
06/2015 - 08/2013
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2022 - 01/2022
3CholesterolIBA
04/2022 - 01/2021
3Glutathione Disulfide (GSSG)FDA LinkGeneric
01/2022 - 04/2016
3Long Noncoding RNAIBA
10/2021 - 12/2017

Therapy/Procedure

102Therapeutics
11/2022 - 09/2006
21Drug Therapy (Chemotherapy)
01/2022 - 03/2007
8Radiotherapy
10/2021 - 11/2007
5Immunotherapy
11/2022 - 10/2019
4Precision Medicine
10/2021 - 11/2015